Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Motor Neurons | 16 | 2012 | 56 | 3.060 |
Why?
|
| Amyotrophic Lateral Sclerosis | 10 | 2019 | 72 | 2.990 |
Why?
|
| Immunity | 2 | 2018 | 22 | 1.270 |
Why?
|
| Spinal Cord | 11 | 2012 | 130 | 1.120 |
Why?
|
| HSP70 Heat-Shock Proteins | 4 | 2014 | 26 | 0.970 |
Why?
|
| Astrocytes | 4 | 2012 | 58 | 0.960 |
Why?
|
| Muscle, Skeletal | 7 | 2018 | 519 | 0.850 |
Why?
|
| Apoptosis | 7 | 2013 | 360 | 0.790 |
Why?
|
| Animals | 31 | 2019 | 7541 | 0.780 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2019 | 16 | 0.690 |
Why?
|
| Neurodegenerative Diseases | 1 | 2019 | 13 | 0.680 |
Why?
|
| Heat-Shock Proteins | 1 | 2019 | 34 | 0.670 |
Why?
|
| Chick Embryo | 12 | 2012 | 74 | 0.640 |
Why?
|
| Immunomodulation | 1 | 2018 | 32 | 0.640 |
Why?
|
| Interleukin-6 | 1 | 2019 | 247 | 0.630 |
Why?
|
| Disease Progression | 1 | 2019 | 594 | 0.580 |
Why?
|
| Inflammation | 1 | 2018 | 530 | 0.490 |
Why?
|
| Cell Survival | 6 | 2010 | 284 | 0.470 |
Why?
|
| Cysteine Endopeptidases | 3 | 1998 | 8 | 0.430 |
Why?
|
| Protein Precursors | 1 | 2012 | 22 | 0.410 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2012 | 37 | 0.400 |
Why?
|
| Neuromuscular Junction | 6 | 2018 | 72 | 0.380 |
Why?
|
| Stilbenes | 1 | 2010 | 23 | 0.370 |
Why?
|
| Cell Separation | 1 | 2011 | 92 | 0.360 |
Why?
|
| Oxidative Stress | 2 | 2008 | 231 | 0.330 |
Why?
|
| Axonal Transport | 1 | 2008 | 3 | 0.310 |
Why?
|
| Synaptic Vesicles | 1 | 2008 | 8 | 0.310 |
Why?
|
| HSC70 Heat-Shock Proteins | 1 | 2008 | 1 | 0.310 |
Why?
|
| Phosphotransferases | 1 | 2007 | 4 | 0.300 |
Why?
|
| Neuroprotective Agents | 1 | 2007 | 28 | 0.300 |
Why?
|
| Disease Models, Animal | 2 | 2010 | 1022 | 0.300 |
Why?
|
| Macrophages | 3 | 1995 | 191 | 0.290 |
Why?
|
| Mice | 10 | 2017 | 2484 | 0.280 |
Why?
|
| Hyperthermia, Induced | 2 | 2014 | 243 | 0.270 |
Why?
|
| Cells, Cultured | 7 | 2013 | 833 | 0.270 |
Why?
|
| Caspases | 3 | 2013 | 39 | 0.260 |
Why?
|
| Extracellular Fluid | 1 | 2005 | 11 | 0.260 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 173 | 0.260 |
Why?
|
| Signal Transduction | 2 | 2007 | 682 | 0.240 |
Why?
|
| Superoxide Dismutase | 3 | 2010 | 45 | 0.240 |
Why?
|
| Cell Death | 6 | 2006 | 77 | 0.230 |
Why?
|
| Cyclin E | 1 | 2003 | 5 | 0.230 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2003 | 9 | 0.230 |
Why?
|
| Cell Cycle | 1 | 2003 | 77 | 0.220 |
Why?
|
| Neurons, Afferent | 1 | 2003 | 56 | 0.220 |
Why?
|
| Humans | 14 | 2019 | 32005 | 0.210 |
Why?
|
| Neuroglia | 2 | 1991 | 30 | 0.200 |
Why?
|
| Case-Control Studies | 2 | 2019 | 898 | 0.180 |
Why?
|
| Nerve Growth Factors | 2 | 2005 | 16 | 0.180 |
Why?
|
| Cell Communication | 2 | 2012 | 32 | 0.170 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 608 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2013 | 633 | 0.160 |
Why?
|
| Mutation | 3 | 2016 | 489 | 0.160 |
Why?
|
| Tracheostomy | 1 | 2019 | 29 | 0.160 |
Why?
|
| Muscle Denervation | 2 | 2017 | 29 | 0.160 |
Why?
|
| Enzyme Precursors | 1 | 1998 | 2 | 0.160 |
Why?
|
| Respiration, Artificial | 1 | 2019 | 98 | 0.160 |
Why?
|
| Neurons | 3 | 2016 | 410 | 0.160 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2017 | 30 | 0.140 |
Why?
|
| Caspase 3 | 2 | 2012 | 33 | 0.140 |
Why?
|
| Brain | 3 | 2016 | 951 | 0.140 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2016 | 2 | 0.140 |
Why?
|
| Time Factors | 4 | 2013 | 2149 | 0.130 |
Why?
|
| Fluorodeoxyuridylate | 1 | 2016 | 23 | 0.130 |
Why?
|
| Ultrasonography | 1 | 2018 | 379 | 0.130 |
Why?
|
| Troponin T | 1 | 2017 | 81 | 0.130 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1995 | 6 | 0.130 |
Why?
|
| Receptors, Opioid | 1 | 1995 | 12 | 0.130 |
Why?
|
| Chemotaxis | 1 | 1995 | 24 | 0.130 |
Why?
|
| Nanoparticles | 1 | 2016 | 52 | 0.130 |
Why?
|
| Antioxidants | 1 | 2016 | 115 | 0.130 |
Why?
|
| Mitochondria | 2 | 2015 | 187 | 0.130 |
Why?
|
| Cohort Studies | 1 | 2019 | 1817 | 0.120 |
Why?
|
| Brain Injuries | 1 | 1995 | 93 | 0.120 |
Why?
|
| Physical Endurance | 1 | 2014 | 36 | 0.120 |
Why?
|
| Mice, Transgenic | 3 | 2016 | 264 | 0.120 |
Why?
|
| Female | 8 | 2019 | 19959 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2012 | 69 | 0.110 |
Why?
|
| Polymers | 1 | 2013 | 64 | 0.110 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2012 | 109 | 0.110 |
Why?
|
| Muscle Strength | 1 | 2014 | 161 | 0.110 |
Why?
|
| Male | 7 | 2019 | 19165 | 0.110 |
Why?
|
| Mice, Mutant Strains | 2 | 2010 | 52 | 0.110 |
Why?
|
| Caspase 7 | 1 | 2012 | 3 | 0.100 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2012 | 4 | 0.100 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2012 | 11 | 0.100 |
Why?
|
| Chickens | 1 | 2012 | 38 | 0.100 |
Why?
|
| Adult | 3 | 2019 | 9345 | 0.100 |
Why?
|
| Glioblastoma | 1 | 2013 | 156 | 0.100 |
Why?
|
| Aging | 2 | 2017 | 946 | 0.100 |
Why?
|
| Geniculate Bodies | 1 | 1991 | 23 | 0.100 |
Why?
|
| Visual Cortex | 1 | 1991 | 35 | 0.100 |
Why?
|
| Aged | 3 | 2019 | 10301 | 0.100 |
Why?
|
| African Americans | 1 | 2019 | 1425 | 0.100 |
Why?
|
| Insulin Resistance | 1 | 2014 | 462 | 0.100 |
Why?
|
| Dissection | 1 | 2011 | 17 | 0.090 |
Why?
|
| Motor Neuron Disease | 1 | 2010 | 4 | 0.090 |
Why?
|
| Immunoglobulins | 1 | 2010 | 15 | 0.090 |
Why?
|
| Biological Specimen Banks | 1 | 2010 | 8 | 0.090 |
Why?
|
| Information Services | 1 | 2010 | 15 | 0.090 |
Why?
|
| Immunohistochemistry | 4 | 2005 | 538 | 0.090 |
Why?
|
| Acetylation | 1 | 2010 | 15 | 0.090 |
Why?
|
| Middle Aged | 3 | 2019 | 11817 | 0.090 |
Why?
|
| Longevity | 1 | 2010 | 24 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2010 | 463 | 0.090 |
Why?
|
| Sirtuin 1 | 1 | 2010 | 38 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2010 | 82 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2007 | 70 | 0.090 |
Why?
|
| Psychomotor Performance | 1 | 2010 | 99 | 0.090 |
Why?
|
| Age Factors | 2 | 2017 | 1188 | 0.090 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2006 | 15 | 0.090 |
Why?
|
| Neoplasms | 1 | 2016 | 726 | 0.080 |
Why?
|
| Body Weight | 1 | 2010 | 310 | 0.080 |
Why?
|
| Microscopy, Interference | 1 | 2008 | 2 | 0.080 |
Why?
|
| Motion Perception | 1 | 2008 | 5 | 0.080 |
Why?
|
| Viscosity | 1 | 2008 | 22 | 0.080 |
Why?
|
| Neurites | 1 | 2008 | 10 | 0.080 |
Why?
|
| Riluzole | 1 | 2007 | 5 | 0.080 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2007 | 2 | 0.080 |
Why?
|
| Diet | 1 | 2010 | 391 | 0.080 |
Why?
|
| Drug Interactions | 1 | 2008 | 78 | 0.080 |
Why?
|
| Oligopeptides | 1 | 2008 | 45 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 99 | 0.080 |
Why?
|
| Kinetics | 1 | 2008 | 209 | 0.070 |
Why?
|
| Brain Neoplasms | 1 | 2013 | 638 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 35 | 0.070 |
Why?
|
| Hindlimb | 1 | 2007 | 54 | 0.070 |
Why?
|
| Hydrogen Peroxide | 1 | 2008 | 83 | 0.070 |
Why?
|
| Fever | 1 | 2007 | 61 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 166 | 0.070 |
Why?
|
| Culture Media, Conditioned | 1 | 2007 | 51 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2007 | 289 | 0.070 |
Why?
|
| Amino Acid Sequence | 2 | 1998 | 285 | 0.070 |
Why?
|
| Gene Deletion | 1 | 2006 | 67 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2008 | 226 | 0.070 |
Why?
|
| Molecular Sequence Data | 2 | 1998 | 359 | 0.070 |
Why?
|
| Movement | 1 | 2006 | 51 | 0.070 |
Why?
|
| Behavior, Animal | 1 | 2007 | 250 | 0.070 |
Why?
|
| Calcium | 1 | 2008 | 307 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 767 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2005 | 7 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2005 | 84 | 0.060 |
Why?
|
| Motor Activity | 1 | 2007 | 325 | 0.060 |
Why?
|
| Rats | 3 | 1995 | 1595 | 0.060 |
Why?
|
| Growth Inhibitors | 1 | 2003 | 10 | 0.060 |
Why?
|
| Cerebral Cortex | 2 | 2013 | 126 | 0.060 |
Why?
|
| Animals, Newborn | 2 | 1995 | 114 | 0.060 |
Why?
|
| Genes, bcl-2 | 1 | 2002 | 1 | 0.050 |
Why?
|
| Muscle Contraction | 2 | 2017 | 114 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 1991 | 246 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 495 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2018 | 40 | 0.040 |
Why?
|
| Diaphragm | 1 | 2018 | 39 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 70 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 1998 | 87 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit | 1 | 2017 | 9 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2017 | 91 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2018 | 545 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 1998 | 508 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 877 | 0.030 |
Why?
|
| Action Potentials | 1 | 2017 | 178 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2017 | 117 | 0.030 |
Why?
|
| Microvessels | 1 | 2016 | 25 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2016 | 61 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2016 | 64 | 0.030 |
Why?
|
| Tissue Extracts | 1 | 1995 | 2 | 0.030 |
Why?
|
| Caspase 1 | 1 | 1995 | 7 | 0.030 |
Why?
|
| Morphogenesis | 1 | 1995 | 9 | 0.030 |
Why?
|
| Toes | 1 | 1995 | 15 | 0.030 |
Why?
|
| Chemotactic Factors | 1 | 1995 | 4 | 0.030 |
Why?
|
| Opioid Peptides | 1 | 1995 | 14 | 0.030 |
Why?
|
| Solubility | 1 | 1995 | 36 | 0.030 |
Why?
|
| Nerve Degeneration | 1 | 1995 | 14 | 0.030 |
Why?
|
| Thalamus | 1 | 1995 | 33 | 0.030 |
Why?
|
| Proteins | 1 | 2016 | 144 | 0.030 |
Why?
|
| Diterpenes | 1 | 2014 | 20 | 0.030 |
Why?
|
| European Continental Ancestry Group | 1 | 2019 | 1166 | 0.030 |
Why?
|
| Random Allocation | 1 | 2014 | 226 | 0.030 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2013 | 49 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 115 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2013 | 81 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 2265 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2013 | 291 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2013 | 104 | 0.030 |
Why?
|
| Body Composition | 1 | 2014 | 397 | 0.030 |
Why?
|
| Phagocytes | 1 | 1991 | 5 | 0.030 |
Why?
|
| Antigens | 1 | 1991 | 31 | 0.030 |
Why?
|
| Pregnancy | 1 | 1995 | 997 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 2636 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 726 | 0.020 |
Why?
|
| Semaphorins | 1 | 2010 | 2 | 0.020 |
Why?
|
| Growth Cones | 1 | 2010 | 3 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2010 | 11 | 0.020 |
Why?
|
| Information Management | 1 | 2010 | 2 | 0.020 |
Why?
|
| Tubulin | 1 | 2010 | 12 | 0.020 |
Why?
|
| Computer Security | 1 | 2010 | 7 | 0.020 |
Why?
|
| Serum | 1 | 2010 | 19 | 0.020 |
Why?
|
| Massachusetts | 1 | 2010 | 27 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 27 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2010 | 33 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 3509 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 130 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 3990 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2010 | 51 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2010 | 108 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 153 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 191 | 0.020 |
Why?
|
| Research | 1 | 2010 | 74 | 0.020 |
Why?
|
| Stroke | 1 | 2016 | 585 | 0.020 |
Why?
|
| Ganglia, Spinal | 1 | 2010 | 65 | 0.020 |
Why?
|
| Proteomics | 1 | 2010 | 94 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2010 | 355 | 0.020 |
Why?
|
| Internet | 1 | 2010 | 195 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 301 | 0.020 |
Why?
|
| Vacuoles | 1 | 2006 | 3 | 0.020 |
Why?
|
| Gliosis | 1 | 2006 | 4 | 0.020 |
Why?
|
| Schwann Cells | 1 | 2006 | 5 | 0.020 |
Why?
|
| Denervation | 1 | 2006 | 13 | 0.020 |
Why?
|
| Spinal Nerve Roots | 1 | 2006 | 14 | 0.020 |
Why?
|
| Demyelinating Diseases | 1 | 2006 | 10 | 0.020 |
Why?
|
| Axons | 1 | 2006 | 35 | 0.020 |
Why?
|
| Presynaptic Terminals | 1 | 2006 | 37 | 0.020 |
Why?
|
| Thymidine | 1 | 2005 | 6 | 0.020 |
Why?
|
| Tetanus Toxin | 1 | 2005 | 6 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2005 | 40 | 0.020 |
Why?
|
| Limb Buds | 1 | 2005 | 3 | 0.020 |
Why?
|
| Cell Count | 1 | 2005 | 47 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 105 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2005 | 229 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2005 | 399 | 0.010 |
Why?
|
| Cervical Vertebrae | 1 | 2002 | 44 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2002 | 120 | 0.010 |
Why?
|